Tyler Shimko is an Applied AI Scientist specializing in drug discovery at NVIDIA, a position held since 2024. They served as CEO of Trident Bioscience from 2020 to 2024 and completed a PhD in Genetics at Stanford University, where they were a graduate student from 2015 to 2020. Tyler obtained a Bachelor of Science in Biology from the University of Utah in 2015 and participated in Y Combinator in 2020.
Location
Seattle, United States
This person is not in the org chart
This person is not in any teams
This person is not in any offices